P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders

Frontiers in Neuroscience

Volumn , Issue 8 JUN, 2014, Pages

  Franklin, Kelle M ^a   Asatryan, Liana ^b   Jakowec, Michael W ^c   Trudell, James R ^d   Bell, Richard L ^a   Davies, Daryl L ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Alcohol preferring; Alcoholism; Ivermectin; p2rx4; P2X; P2X4 receptor; Purinergic

Indexed keywords

ALCOHOL; ION CHANNEL; IVERMECTIN; PURINERGIC P2X4 RECEPTOR;

ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; DRINKING BEHAVIOR; DRUG BINDING SITE; DRUG EFFECT; DRUG TARGETING; GENE EXPRESSION; HUMAN; MOLECULAR MODEL; NERVE CELL PLASTICITY; NONHUMAN; PROPHYLAXIS; REVIEW;

EID: 84905051215     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00176     Document Type: Review

References (139)

1. Abbracchio, M. P., Burnstock, G., Verkhratsky, A., and Zimmermann, H. (2009). Purinergic signalling in the nervous system: an overview. Trends Neurosci. 32, 19-29. doi: 10.1016/j.tins.2008.10.001
2. Adelsberger, H., Lepier, A., and Dudel, J. (2000). Activation of rat recombinant alpha(1)beta(2)gamma(2S) GABA(A) receptor by the insecticide ivermectin. Eur. J. Pharmacol. 394, 163-170. doi: 10.1016/S0014-2999(00)00164-3
3. Amadio, S., Montilli, C., Picconi, B., Calabresi, P., and Volonte, C. (2007). Mapping P2X and P2Y receptor proteins in striatum and substantia nigra: an immunohistological study. Purinergic Signal. 3, 389-398. doi: 10.1007/s11302-007-9069-8
4. Andries, M., Van Damme, P., Robberecht, W., and Van Den Bosch, L. (2007). Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 25, 8-16. doi: 10.1016/j.nbd.2006.08.018
5. Asatryan, L., Nam, H. W., Lee, M. R., Thakkar, M. M., Saeed Dar, M., Davies, D. L., et al. (2011). Implication of the purinergic system in alcohol use disorders. Alcohol. Clin. Exp. Res. 35, 584-594. doi: 10.1111/j.1530-0277.2010.01379.x
6. Asatryan, L., Popova, M., Perkins, D., Trudell, J. R., Alkana, R. L., and Davies, D. L. (2010). Ivermectin antagonizes ethanol inhibition in purinergic P2X4 receptors. J. Pharmacol. Exp. Ther. 334, 720-728. doi: 10.1124/jpet.110.167908
7. Asatryan, L., Popova, M., Woodward, J. J., King, B. F., Alkana, R. L., and Davies, D. L. (2008). Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors. Neuropharmacology 55, 835-843. doi: 10.1016/j.neuropharm.2008.06.044
8. Asatryan, L., Yardley, M. M., Khoja, S., Trudell, J. R., Hyunh, N., Louie, S. G., et al. (2014). Avermectins differentially affect ethanol intake and receptor function: implications for developing new therapeutics for alcohol use disorders. Int. J. Neuropsychopharmacol. 17, 907-916. doi: 10.1017/S1461145713001703
9. Baxter, A. W., Choi, S. J., Sim, J. A., and North, R. A. (2011). Role of P2X4 receptors in synaptic strengthening in mouse CA1 hippocampal neurons. Eur. J. Neurosci. 34, 213-220. doi: 10.1111/j.1460-9568.2011.07763.x
10. Betz, H. (1990). Ligand-gated ion channels in the brain: the amino acid receptor superfamily. Neuron 5, 383-392. doi: 10.1016/0896-6273(90)90077-S
11. Bo, X., Zhang, Y., Nassar, M., Burnstock, G., and Schoepfer, R. (1995). A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375, 129-133. doi: 10.1016/0014-5793(95)01203-Q
12. Bonan, C. D., Roesler, R., Pereira, G. S., Battastini, A. M., Izquierdo, I., and Sarkis, J. J. (2000). Learning-specific decrease in synaptosomal ATP diphosphohydrolase activity from hippocampus and entorhinal cortex of adult rats. Brain Res. 854, 253-256. doi: 10.1016/S0006-8993(99)02300-8
13. Borst, P., and Schinkel, A. H. (1996). What have we learnt thus far from mice with disrupted P-glycoprotein genes? Eur. J. Cancer 32A, 985-990. doi: 10.1016/0959-8049(96)00063-9
14. Bortolato, M., Yardley, M. M., Khoja, S., Godar, S. C., Asatryan, L., Finn, D. A., et al. (2013). Pharmacological insights into the role of P2X4 receptors in behavioural regulation: lessons from ivermectin. Int. J. Neuropsychopharmacol. 16, 1059-1070. doi: 10.1017/S1461145712000909
15. Bouchery, E. E., Harwood, H. J., Sacks, J. J., Simon, C. J., and Brewer, R. D. (2011). Economic costs of excessive alcohol consumption in the U.S., 2006. Am. J. Prev. Med. 41, 516-524. doi: 10.1016/j.amepre.2011.06.045
16. Buell, G., Lewis, C., Collo, G., North, R. A., and Surprenant, A. (1996). An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J. 15, 55-62.
17. Burnstock, G. (2004). Introduction: P2 receptors. Curr. Top. Med. Chem. 4, 793-803. doi: 10.2174/1568026043451014
18. Burnstock, G., and Knight, G. E. (2004). Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol. 240, 31-304. doi: 10.1016/S0074-7696(04)40002-3
19. Burnstock, G., Krugel, U., Abbracchio, M. P., and Illes, P. (2011). Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol. 95, 229-274. doi: 10.1016/j.pneurobio.2011.08.006
20. Cardoso, R. A., Brozowski, S. J., Chavez-Noriega, L. E., Harpold, M., Valenzuela, C. F., and Harris, R. A. (1999). Effects of ethanol on recombinant human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 289, 774-780.
21. Choi, Y. M., Jang, J. Y., Jang, M., Kim, S. H., Kang, Y. K., Cho, H., et al. (2009). Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta. Neuroscience 160, 587-595. doi: 10.1016/j.neuroscience.2009.02.067
22. Coddou, C., Yan, Z., Obsil, T., Huidobro-Toro, J. P., and Stojilkovic, S. S. (2011). Activation and regulation of purinergic P2X receptor channels. Pharmacol. Rev. 63, 641-683. doi: 10.1124/pr.110.003129
23. Colombo, G., Orru, A., Lai, P., Cabras, C., Maccioni, P., Rubio, M., et al. (2007). The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence. Mol. Neurobiol. 36, 102-112. doi: 10.1007/s12035-007-0017-y
24. Cully, D. F., Vassilatis, D. K., Liu, K. K., Paress, P. S., Schaeffer, J. M., and Arena, J. P. (1994). Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 371, 707-711. doi: 10.1038/371707a0
25. Cunha, R. A., and Ribeiro, J. A. (2000). ATP as a presynaptic modulator. Life Sci. 68, 119-137. doi: 10.1016/S0024-3205(00)00923-1
26. Cunha, R. A., Vizi, E. S., Ribeiro, J. A., and Sebastiao, A. M. (1996). Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J. Neurochem. 67, 2180-2187. doi: 10.1046/j.1471-4159.1996.67052180.x
27. Dadarkar, S. S., Deore, M. D., and Gatne, M. M. (2007). Comparative evaluation of acute toxicity of ivermectin by two methods after single subcutaneous administration in rats. Regul. Toxicol. Pharmacol. 47, 257-260. doi: 10.1016/j.yrtph.2006.10.009
28. Daly, J. W. (2005). Nicotinic agonists, antagonists, and modulators from natural sources. Cell. Mol. Neurobiol. 25, 513-552. doi: 10.1007/s10571-005-3968-4
29. D'Ambrosi, N., Murra, B., Cavaliere, F., Amadio, S., Bernardi, G., Burnstock, G., et al. (2001). Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells. Neuroscience 108, 527-534. doi: 10.1016/S0306-4522(01)00431-6
30. Davies, D. L., and Alkana, R. L. (2001). Ethanol enhances GABAA receptor function in short sleep and long sleep mouse brain membranes. Alcohol. Clin. Exp. Res. 25, 478-483. doi: 10.1111/j.1530-0277.2001.tb02238.x
31. Davies, D. L., Bortolato, M., Finn, D. A., Ramaker, M. J., Barak, S., Ron, D., et al. (2013). Recent advances in the discovery and preclinical testing of novel compounds for the prevention and/or treatment of alcohol use disorders. Alcohol. Clin. Exp. Res. 37, 8-15. doi: 10.1111/j.1530-0277.2012.01846.x
32. Davies, D. L., Kochegarov, A. A., Kuo, S. T., Kulkarni, A. A., Woodward, J. J., King, B. F., et al. (2005). Ethanol differentially affects ATP-gated P2X(3) and P2X(4) receptor subtypes expressed in Xenopus oocytes. Neuropharmacology 49, 243-253. doi: 10.1016/j.neuropharm.2005.03.015
33. Davies, D. L., Machu, T. K., Guo, Y., and Alkana, R. L. (2002). Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. Alcohol. Clin. Exp. Res. 26, 773-778. doi: 10.1111/j.1530-0277.2002.tb02604.x
34. Davis, J. A., Paylor, R., McDonald, M. P., Libbey, M., Ligler, A., Bryant, K., et al. (1999). Behavioral effects of ivermectin in mice. Lab. Anim. Sci. 49, 288-296.
35. Davis, T. J., and de Fiebre, C. M. (2006). Alcohol's actions on neuronal nicotinic acetylcholine receptors. Alcohol Res. Health 29, 179-185.
36. Dawson, G. R., Wafford, K. A., Smith, A., Marshall, G. R., Bayley, P. J., Schaeffer, J. M., et al. (2000). Anticonvulsant and adverse effects of avermectin analogs in mice are mediated through the gamma-aminobutyric acid(A) receptor. J. Pharmacol. Exp. Ther. 295, 1051-1060.
37. Deitrich, R. A., Dunwiddie, T. V., Harris, R. A., and Erwin, V. G. (1989). Mechanism of action of ethanol: initial central nervous system actions. Pharmacol. Rev. 41, 489-537.
38. Dent, J. A., Davis, M. W., and Avery, L. (1997). avr-15 encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in Caenorhabditis elegans. EMBO J. 16, 5867-5879. doi: 10.1093/emboj/16.19.5867
39. Dildy-Mayfield, J. E., Mihic, S. J., Liu, Y., Deitrich, R. A., and Harris, R. A. (1996). Actions of long chain alcohols on GABAA and glutamate receptors: relation to in vivo effects. Br. J. Pharmacol. 118, 378-384. doi: 10.1111/j.1476-5381.1996.tb15413.x
40. Edwards, G., Dingsdale, A., Helsby, N., Orme, M. L., and Breckenridge, A. M. (1988). The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution. Eur. J. Clin. Pharmacol. 35, 681-684. doi: 10.1007/BF00637608
41. Fox, L. M. (2006). Ivermectin: uses and impact 20 years on. Curr. Opin. Infect. Dis. 19, 588-593. doi: 10.1097/QCO.0b013e328010774c
42. Fujii, S. (2004). ATP- and adenosine-mediated signaling in the central nervous system: the role of extracellular ATP in hippocampal long-term potentiation. J. Pharmacol. Sci. 94, 103-106. doi: 10.1254/jphs.94.103
43. Garcia-Guzman, M., Soto, F., Gomez-Hernandez, J. M., Lund, P. E., and Stuhmer, W. (1997). Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. Mol. Pharmacol. 51, 109-118.
44. Geary, T. G. (2005). Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. 21, 530-532. doi: 10.1016/j.pt.2005.08.014
45. Gewiss, M., Heidbreder, C., Opsomer, L., and Durbin, P. (1991). Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcohol. 26, 129-137.
46. Gonzales, R. A., Job, M. O., and Doyon, W. M. (2004). The role of mesolimbic dopamine in the development and maintenance of ethanol reinforcement. Pharmacol. Ther. 103, 121-146. doi: 10.1016/j.pharmthera.2004.06.002
47. Gonzalez, P., Gonzalez, F. A., and Ueno, K. (2012). Ivermectin in human medicine, an overview of the current status of its clinical applications. Curr. Pharm. Biotechnol. 13, 1103-1109. doi: 10.2174/138920112800399248
48. Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, S. P., Dufour, M. C., and Pickering, R. P. (2004). The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United States, 1991-1992 and 2001-2002. Drug Alcohol Depend. 74, 223-234. doi: 10.1016/j.drugalcdep.2004.02.004
49. Grant, K. A. (1994). Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav. Pharmacol. 5, 383-404. doi: 10.1097/00008877-199408000-00003
50. Guzzo, C. A., Furtek, C. I., Porras, A. G., Chen, C., Tipping, R., Clineschmidt, C. M., et al. (2002). Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J. Clin. Pharmacol. 42, 1122-1133. doi: 10.1177/009127002401382731
51. Harris, A. H., Kivlahan, D. R., Bowe, T., and Humphreys, K. N. (2010). Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr. Serv. 61, 392-398. doi: 10.1176/appi.ps.61.4.392
52. Harris, R. A. (1999). Ethanol actions on multiple ion channels: which are important? Alcohol. Clin. Exp. Res. 23, 1563-1570. doi: 10.1111/j.1530-0277.1999.tb04045.x
53. Hattori, M., and Gouaux, E. (2012). Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485, 207-212. doi: 10.1038/nature11010
54. Heilig, M., and Egli, M. (2006). Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol. Ther. 111, 855-876. doi: 10.1016/j.pharmthera.2006.02.001
55. Heilig, M., Goldman, D., Berrettini, W., and O'Brien, C. P. (2011). Pharmacogenetic approaches to the treatment of alcohol addiction. Nat. Rev. Neurosci. 12, 670-684. doi: 10.1038/nrn3110
56. Heine, C., Wegner, A., Grosche, J., Allgaier, C., Illes, P., and Franke, H. (2007). P2 receptor expression in the dopaminergic system of the rat brain during development. Neuroscience 149, 165-181. doi: 10.1016/j.neuroscience.2007.07.015
57. Hibbs, R. E., and Gouaux, E. (2011). Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474, 54-60. doi: 10.1038/nature10139
58. Ikeda, T. (2003). Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy. Nihon Yakurigaku Zasshi 122, 527-538. doi: 10.1254/fpj.122.527
59. Jarvis, M. F., and Khakh, B. S. (2009). ATP-gated P2X cation-channels. Neuropharmacology 56, 208-215. doi: 10.1016/j.neuropharm.2008.06.067
60. Jelinkova, I., Vavra, V., Jindrichova, M., Obsil, T., Zemkova, H. W., Zemkova, H., et al. (2008). Identification of P2X(4) receptor transmembrane residues contributing to channel gating and interaction with ivermectin. Pflugers Arch. 456, 939-950. doi: 10.1007/s00424-008-0450-4
61. Jelinkova, I., Yan, Z., Liang, Z., Moonat, S., Teisinger, J., Stojilkovic, S. S., et al. (2006). Identification of P2X4 receptor-specific residues contributing to the ivermectin effects on channel deactivation. Biochem. Biophys. Res. Commun. 349, 619-625. doi: 10.1016/j.bbrc.2006.08.084
62. Jiang, R., Taly, A., and Grutter, T. (2013). Moving through the gate in ATP-activated P2X receptors. Trends Biochem. Sci. 38, 20-29. doi: 10.1016/j.tibs.2012.10.006
63. Johnson, B. A. (2010). Medication treatment of different types of alcoholism. Am. J. Psychiatry 167, 630-639. doi: 10.1176/appi.ajp.2010.08101500
64. Johnson, B. A., Rosenthal, N., Capece, J. A., Wiegand, F., Mao, L., Beyers, K., et al. (2007). Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298, 1641-1651. doi: 10.1001/jama.298.14.1641
65. Kanjhan, R., Housley, G. D., Burton, L. D., Christie, D. L., Kippenberger, A., Thorne, P. R., et al. (1999). Distribution of the P2X2 receptor subunit of the ATP-gated ion channels in the rat central nervous system. J. Comp. Neurol. 407, 11-32. doi: 10.1002/(SICI)1096-9861(19990428)407:1%3C11::AID-CNE2%3E3.3.CO;2-I
66. Kawate, T., Michel, J. C., Birdsong, W. T., and Gouaux, E. (2009). Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460, 592-598. doi: 10.1038/nature08198
67. Kessels, H. W., and Malinow, R. (2009). Synaptic AMPA receptor plasticity and behavior. Neuron 61, 340-350. doi: 10.1016/j.neuron.2009.01.015
68. Khakh, B. S. (2001). Molecular physiology of P2X receptors and ATP signalling at synapses. Nat. Rev. Neurosci. 2, 165-174. doi: 10.1038/35058521
69. Khakh, B. S. (2009). ATP-gated P2X receptors on excitatory nerve terminals onto interneurons initiate a form of asynchronous glutamate release. Neuropharmacology 56, 216-222. doi: 10.1016/j.neuropharm.2008.06.011
70. Khakh, B. S., Bao, X. R., Labarca, C., and Lester, H. A. (1999). Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat. Neurosci. 2, 322-330. doi: 10.1038/7233
71. Khakh, B. S., and North, R. A. (2006). P2X receptors as cell-surface ATP sensors in health and disease. Nature 442, 527-532. doi: 10.1038/nature04886
72. Kimpel, M. W., Strother, W. N., McClintick, J. N., Carr, L. G., Liang, T., Edenberg, H. J., et al. (2007). Functional gene expression differences between inbred alcohol-preferring and -non-preferring rats in five brain regions. Alcohol 41, 95-132. doi: 10.1016/j.alcohol.2007.03.003
73. Kittner, H., Hoffmann, E., Krugel, U., and Illes, P. (2004). P2 receptor-mediated effects on the open field behaviour of rats in comparison with behavioural responses induced by the stimulation of dopamine D2-like and by the blockade of ionotrophic glutamate receptors. Behav. Brain Res. 149, 197-208. doi: 10.1016/S0166-4328(03)00227-4
74. Klein, K., Aeschlimann, A., Jordan, S., Gay, R., Gay, S., and Sprott, H. (2012). ATP induced brain-derived neurotrophic factor expression and release from osteoarthritis synovial fibroblasts is mediated by purinergic receptor P2X4. PLoS ONE 7:e36693. doi: 10.1371/journal.pone.0036693
75. Kosten, T. A. (2011). Pharmacologically targeting the P2rx4 gene on maintenance and reinstatement of alcohol self-administration in rats. Pharmacol. Biochem. Behav. 98, 533-538. doi: 10.1016/j.pbb.2011.02.026
76. Krugel, U., Kittner, H., Franke, H., and Illes, P. (2003). Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo. Synapse 47, 134-142. doi: 10.1002/syn.10162
77. Krugel, U., Spies, O., Regenthal, R., Illes, P., and Kittner, H. (2004). P2 receptors are involved in the mediation of motivation-related behavior. Purinergic Signal. 1, 21-29. doi: 10.1007/s11302-004-4745-4
78. Lalo, U., Verkhratsky, A., and Pankratov, Y. (2007). Ivermectin potentiates ATP-induced ion currents in cortical neurones: evidence for functional expression of P2X4 receptors? Neurosci. Lett. 421, 158-162. doi: 10.1016/j.neulet.2007.03.078
79. Lankas, G. R., Cartwright, M. E., and Umbenhauer, D. (1997). P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol. Appl. Pharmacol. 143, 357-365. doi: 10.1006/taap.1996.8086
80. Lerchner, W., Xiao, C., Nashmi, R., Slimko, E. M., van Trigt, L., Lester, H. A., et al. (2007). Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl- channel. Neuron 54, 35-49. doi: 10.1016/j.neuron.2007.02.030
81. Lespine, A., Martin, S., Dupuy, J., Roulet, A., Pineau, T., Orlowski, S., et al. (2007). Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 30, 84-94. doi: 10.1016/j.ejps.2006.10.004
82. Li, C., Aguayo, L., Peoples, R. W., and Weight, F. F. (1993). Ethanol inhibits a neuronal ATP-gated ion channel. Mol. Pharmacol. 44, 871-875.
83. Li, C., Peoples, R. W., and Weight, F. F. (1998). Ethanol-induced inhibition of a neuronal P2X purinoceptor by an allosteric mechanism. Br. J. Pharmacol. 123, 1-3. doi: 10.1038/sj.bjp.0701599
84. Litten, R. Z., Egli, M., Heilig, M., Cui, C., Fertig, J. B., Ryan, M. L., et al. (2012). Medications development to treat alcohol dependence: a vision for the next decade. Addict. Biol. 17, 513-527. doi: 10.1111/j.1369-1600.2012.00454.x
85. Lynagh, T., Webb, T. I., Dixon, C. L., Cromer, B. A., and Lynch, J. W. (2011). Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel. J. Biol. Chem. 286, 43913-43924. doi: 10.1074/jbc.M111.262634
86. Ma, B., and Nussinov, R. (2007). Trp/Met/Phe hot spots in protein-protein interactions: potential targets in drug design. Curr. Top. Med. Chem. 7, 999-1005. doi: 10.2174/156802607780906717
87. McBride, W. J., Kimpel, M. W., McClintick, J. N., Ding, Z. M., Hyytia, P., Colombo, G., et al. (2012). Gene expression in the ventral tegmental area of 5 pairs of rat lines selectively bred for high or low ethanol consumption. Pharmacol. Biochem. Behav. 102, 275-285. doi: 10.1016/j.pbb.2012.04.016
88. Menez, C., Mselli-Lakhal, L., Foucaud-Vignault, M., Balaguer, P., Alvinerie, M., and Lespine, A. (2012). Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line. Biochem. Pharmacol. 83, 269-278. doi: 10.1016/j.bcp.2011.10.010
89. Mihic, S. J., Ye, Q., Wick, M. J., Koltchine, V. V., Krasowski, M. D., Finn, S. E., et al. (1997). Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389, 385-389. doi: 10.1038/38738
90. Monaghan, D. T., Bridges, R. J., and Cotman, C. W. (1989). The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29, 365-402. doi: 10.1146/annurev.pa.29.040189.002053
91. Naimi, T. S. (2011). The cost of alcohol and its corresponding taxes in the U.S.: a massive public subsidy of excessive drinking and alcohol industries. Am. J. Prev. Med. 41, 546-547. doi: 10.1016/j.amepre.2011.08.001
92. Omura, S. (2008). Ivermectin: 25 years and still going strong. Int. J. Antimicrob. Agents 31, 91-98. doi: 10.1016/j.ijantimicag.2007.08.023
93. Ortells, M. O., and Lunt, G. G. (1995). Evolutionary history of the ligand-gated ion-channel superfamily of receptors. Trends Neurosci. 18, 121-127. doi: 10.1016/0166-2236(95)93887-4
94. Ostrovskaya, O., Asatryan, L., Wyatt, L., Popova, M., Li, K., Peoples, R. W., et al. (2011). Ethanol is a fast channel inhibitor of P2X4 receptors. J. Pharmacol. Exp. Ther. 337, 171-179. doi: 10.1124/jpet.110.176990
95. Pankratov, Y., Lalo, U., Krishtal, O. A., and Verkhratsky, A. (2009). P2X receptors and synaptic plasticity. Neuroscience 158, 137-148. doi: 10.1016/j.neuroscience.2008.03.076
96. Pankratov, Y. V., Lalo, U. V., and Krishtal, O. A. (2002). Role for P2X receptors in long-term potentiation. J. Neurosci. 22, 8363-8369.
97. Pierce, R. C., and Kumaresan, V. (2006). The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci. Biobehav. Rev. 30, 215-238. doi: 10.1016/j.neubiorev.2005.04.016
98. Popova, M., Asatryan, L., Ostrovskaya, O., Wyatt, L. R., Li, K., Alkana, R. L., et al. (2010). A point mutation in the ectodomain-transmembrane 2 interface eliminates the inhibitory effects of ethanol in P2X4 receptors. J. Neurochem. 112, 307-317. doi: 10.1111/j.1471-4159.2009.06460.x
99. Popova, M., Trudell, J., Li, K., Alkana, R., Davies, D., and Asatryan, L. (2013). Tryptophan 46 is a site for ethanol and ivermectin action in P2X4 receptors. Purinergic Signal. 9, 621-632. doi: 10.1007/s11302-013-9373-4
100. Priel, A., and Silberberg, S. D. (2004). Mechanism of ivermectin facilitation of human P2X4 receptor channels. J. Gen. Physiol. 123, 281-293. doi: 10.1085/jgp.200308986
101. Rewal, M., Jurd, R., Gill, T. M., He, D. Y., Ron, D., and Janak, P. H. (2009). Alpha4-containing GABAA receptors in the nucleus accumbens mediate moderate intake of alcohol. J. Neurosci. 29, 543-549. doi: 10.1523/JNEUROSCI.3199-08.2009
102. Richard-Lenoble, D., Chandenier, J., and Gaxotte, P. (2003). Ivermectin and filariasis. Fundam. Clin. Pharmacol. 17, 199-203. doi: 10.1046/j.1472-8206.2003.00170.x
103. Rubio, M. E., and Soto, F. (2001). Distinct Localization of P2X receptors at excitatory postsynaptic specializations. J. Neurosci. 21, 641-653.
104. Rucker, B., Pereira, G. S., Furstenau, C. R., Izquierdo, I., Bonan, C. D., and Sarkis, J. J. (2004). Inhibitory avoidance task reveals differences in ectonucleotidase activities between male and female rats. Neurochem. Res. 29, 2231-2237. doi: 10.1007/s11064-004-7030-6
105. 2+ flux in ligand-gated cation channel (P2X4) by actions on lateral portals. J. Biol. Chem. 287, 7594-7602. doi: 10.1074/jbc.M111.322461
106. Sattelle, D. B., Buckingham, S. D., Akamatsu, M., Matsuda, K., Pienaar, I. S., Jones, A. K., et al. (2009). Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors. Biochem. Pharmacol. 78, 836-843. doi: 10.1016/j.bcp.2009.06.020
107. Shan, Q., Haddrill, J. L., and Lynch, J. W. (2001). Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J. Biol. Chem. 276, 12556-12564. doi: 10.1074/jbc.M011264200
108. Shu, E. N., Onwujekwe, E. O., and Okonkwo, P. O. (2000). Do alcoholic beverages enhance availability of ivermectin? Eur. J. Clin. Pharmacol. 56, 437-438. doi: 10.1007/s002280000120
109. Silberberg, S. D., Li, M., and Swartz, K. J. (2007). Ivermectin Interaction with transmembrane helices reveals widespread rearrangements during opening of P2X receptor channels. Neuron 54, 263-274. doi: 10.1016/j.neuron.2007.03.020
110. Sim, J. A., Chaumont, S., Jo, J., Ulmann, L., Young, M. T., Cho, K., et al. (2006). Altered hippocampal synaptic potentiation in P2X4 knock-out mice. J. Neurosci. 26, 9006-9009. doi: 10.1523/JNEUROSCI.2370-06.2006
111. Sim, J. A., Park, C. K., Oh, S. B., Evans, R. J., and North, R. A. (2007). P2X1 and P2X4 receptor currents in mouse macrophages. Br. J. Pharmacol. 152, 1283-1290. doi: 10.1038/sj.bjp.0707504
112. Sommer, B., Monyer, H., Wisden, W., Verdoorn, T. A., Burnashev, N., Sprengel, R., et al. (1992). Glutamate-gated ion channels in the brain. Genetic mechanism for generating molecular and functional diversity. Arzneimittelforschung 42, 209-210.
113. Soto, F., Garcia-Guzman, M., and Stuhmer, W. (1997). Cloned ligand-gated channels activated by extracellular ATP (P2X receptors). J. Membr. Biol. 160, 91-100. doi: 10.1007/s002329900298
114. Spinosa, H. S., Stilck, S. R., and Bernardi, M. M. (2002). Possible anxiolytic effects of ivermectin in rats. Vet. Res. Commun. 26, 309-321. doi: 10.1023/A:1016094726033
115. Steensland, P., Simms, J. A., Holgate, J., Richards, J. K., and Bartlett, S. E. (2007). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc. Natl. Acad. Sci. U.S.A. 104, 12518-12523. doi: 10.1073/pnas.0705368104
116. Sun, Y. J., Long, D. X., Li, W., Hou, W. Y., Wu, Y. J., and Shen, J. Z. (2010). Effects of avermectins on neurite outgrowth in differentiating mouse neuroblastoma N2a cells. Toxicol. Lett. 192, 206-211. doi: 10.1016/j.toxlet.2009.10.021
117. Surprenant, A., and North, R. A. (2009). Signaling at purinergic P2X receptors. Annu. Rev. Physiol. 71, 333-359. doi: 10.1146/annurev.physiol.70.113006.100630
118. Tabakoff, B., Saba, L., Printz, M., Flodman, P., Hodgkinson, C., Goldman, D., et al. (2009). Genetical genomic determinants of alcohol consumption in rats and humans. BMC Biol. 7:70. doi: 10.1186/1741-7007-7-70
119. Tatko, C. D., and Waters, M. L. (2004). Investigation of the nature of the methionine-pi interaction in beta-hairpin peptide model systems. Protein Sci. 13, 2515-2522. doi: 10.1110/ps.04820104
120. Torres, G. E., Egan, T. M., and Voigt, M. M. (1999). Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J. Biol. Chem. 274, 6653-6659. doi: 10.1074/jbc.274.10.6653
121. Trailovic, S. M., Ivanovic, S. R., and Varagic, V. M. (2011). Ivermectin effects on motor coordination and contractions of isolated rat diaphragm. Res. Vet. Sci. 91, 426-433. doi: 10.1016/j.rvsc.2010.09.016
122. Trailovic, S. M., and Varagic, V. M. (2007). The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine. Vet. Res. Commun. 31, 863-872. doi: 10.1007/s11259-007-0050-3
123. Trang, T., Beggs, S., Wan, X., and Salter, M. W. (2009). P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 29, 3518-3528. doi: 10.1523/JNEUROSCI.5714-08.2009
124. Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., et al. (2003). P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424, 778-783. doi: 10.1038/nature01786
125. Ulmann, L., Hatcher, J. P., Hughes, J. P., Chaumont, S., Green, P. J., Conquet, F., et al. (2008). Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 28, 11263-11268. doi: 10.1523/JNEUROSCI.2308-08.2008
126. Ulmann, L., Levavasseur, F., Avignone, E., Peyroutou, R., Hirbec, H., Audinat, E., et al. (2013). Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus. Glia 61, 1306-1319. doi: 10.1002/glia.22516
127. Vavra, V., Bhattacharya, A., and Zemkova, H. (2011). Facilitation of glutamate and GABA release by P2X receptor activation in supraoptic neurons from freshly isolated rat brain slices. Neuroscience 188, 1-12. doi: 10.1016/j.neuroscience.2011.04.067
128. Vengeliene, V., Bilbao, A., Molander, A., and Spanagel, R. (2008). Neuropharmacology of alcohol addiction. Br. J. Pharmacol. 154, 299-315. doi: 10.1038/bjp.2008.30
129. Wang, Q., and Lynch, J. W. (2012). A comparison of glycine- and ivermectin-mediated conformational changes in the glycine receptor ligand-binding domain. Int. J. Biochem. Cell Biol. 44, 335-340. doi: 10.1016/j.biocel.2011.11.005
130. Wee, Y. V. (2010). Inflammation in neurological disorders: a help or a hindrance? Neuroscientist 16, 408-420. doi: 10.1177/1073858410371379
131. Weight, F. F., Aguayo, L. G., White, G., Lovinger, D. M., and Peoples, R. W. (1992). GABA- and glutamate-gated ion channels as molecular sites of alcohol and anesthetic action. Adv. Biochem. Psychopharmacol. 47, 335-347.
132. Weight, F. F., Li, C., and Peoples, R. W. (1999). Alcohol action on membrane ion channels gated by extracellular ATP (P2X receptors). Neurochem. Int. 35, 143-152. doi: 10.1016/S0197-0186(99)00056-X
133. Woodward, J. J. (2000). Ethanol and NMDA receptor signaling. Crit. Rev. Neurobiol. 14, 69-89. doi: 10.1615/CritRevNeurobiol.v14.i1.40
134. Wyatt, L. R., Finn, D. A., Khoja, S., Yardley, M. M., Asatryan, L., Alkana, R. L., et al. (2014). Contribution of P2X4 receptors to ethanol intake in male C57BL/6 mice. Neurochem. Res. 39, 1127-1139. doi: 10.1007/s11064-014-1271-9
135. Xiao, C., Zhou, C., Li, K., Davies, D. L., and Ye, J. H. (2008). Purinergic type 2 receptors at GABAergic synapses on ventral tegmental area dopamine neurons are targets for ethanol action. J. Pharmacol. Exp. Ther. 327, 196-205. doi: 10.1124/jpet.108.139766
136. Xiong, K., Hu, X. Q., Stewart, R. R., Weight, F. F., and Li, C. (2005). The mechanism by which ethanol inhibits rat P2X4 receptors is altered by mutation of histidine 241. Br. J. Pharmacol. 145, 576-586. doi: 10.1038/sj.bjp.0706192
137. Xiong, K., Li, C., and Weight, F. F. (2000). Inhibition by ethanol of rat P2X(4) receptors expressed in Xenopus oocytes. Br. J. Pharmacol. 130, 1394-1398. doi: 10.1038/sj.bjp.0703439
138. Yamazaki, Y., Kaneko, K., Fujii, S., Kato, H., and Ito, K. (2003). Long-term potentiation and long-term depression induced by local application of ATP to hippocampal CA1 neurons of the guinea pig. Hippocampus 13, 81-92. doi: 10.1002/hipo.7999
139. Yardley, M. M., Wyatt, L., Khoja, S., Asatryan, L., Ramaker, M. J., Finn, D. A., et al. (2012). Ivermectin reduces alcohol intake and preference in mice. Neuropharmacology 63, 190-201. doi: 10.1016/j.neuropharm.2012.03.014